QQ客服 官方微博 反馈留言

	Immune Checkpoint in Glioblastoma: Promising and Challenging.
	Huang, Jing; Liu, Fangkun; Liu, Zhixiong; Tang, Hui; Wu, Haishan; Gong, Qianni; Chen, Jindong*
刊名	Frontiers in pharmacology
	2017
卷号	8期号:MAY页码:242
关键词	CTLA-4 Glioblastoma PD-1 PD-L1 checkpoint immunotherapy
ISSN号	1663-9812
DOI	10.3389/fphar.2017.00242
URL标识	查看原文
WOS记录号	WOS:000402249200002
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3319892
专题	中南大学
作者单位	1.[Tang, Hui 2.Huang, Jing 3.Wu, Haishan 4.Chen, Jindong] Cent S Univ, Xiangya Hosp 2, Dept Psychiat, Changsha, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Huang, Jing,Liu, Fangkun,Liu, Zhixiong,et al. Immune Checkpoint in Glioblastoma: Promising and Challenging.[J]. Frontiers in pharmacology,2017,8(MAY):242.
APA	Huang, Jing.,Liu, Fangkun.,Liu, Zhixiong.,Tang, Hui.,Wu, Haishan.,...&Chen, Jindong*.(2017).Immune Checkpoint in Glioblastoma: Promising and Challenging..Frontiers in pharmacology,8(MAY),242.
MLA	Huang, Jing,et al."Immune Checkpoint in Glioblastoma: Promising and Challenging.".Frontiers in pharmacology 8.MAY(2017):242.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。